AbVance: increasing our knowledge of antibody structural space to enable faster and better decision making in antibody drug discovery
Benz, J., Georges, G.To be published.
Experimental Data Snapshot
Starting Model: other
View more details
wwPDB Validation   3D Report Full Report
Entity ID: 1 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
fAB heavy chain | A, C [auth H] | 227 | Homo sapiens | Mutation(s): 0  | |
Entity Groups   | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
Sequence AnnotationsExpand | |||||
|
Entity ID: 2 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
fAB light chain | B, D [auth L] | 214 | Homo sapiens | Mutation(s): 0  | |
Entity Groups   | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
Sequence AnnotationsExpand | |||||
|
Length ( Å ) | Angle ( ˚ ) |
---|---|
a = 51.984 | α = 117.11 |
b = 69.169 | β = 89.5 |
c = 77.667 | γ = 103.39 |
Software Name | Purpose |
---|---|
BUSTER | refinement |
XDS | data reduction |
SADABS | data scaling |
PHASER | phasing |